Literature DB >> 10872742

Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain.

T Moos1, D Trinder, E H Morgan.   

Abstract

We examined whether high levels of circulatory iron may cause iron accumulation in the brain. In particular, we focussed on the substantia nigra and basal ganglia as several papers have indicated that iron may accumulate here and cause death of dopaminergic neurons. Normal mice and a mouse model of hereditary haemochromatosis, the beta2-microglobulin (beta2m) knock out [beta2m (-/-)] mouse, which has high levels of circulating iron due to increased iron absorption, were examined. The iron concentration in livers were: 170+/-15 microg/g (mean +/- SD) in controls and 1010+/-50 microg/g in beta2m (-/-) mice (p<0.001), whereas in the brain the respective values were 47 +/-1 microg/g and 53+/-2 microg/g (p<0.02). Hence, the difference between cerebral iron levels of normal and beta2m (-/-) mice was small. Histological examination of the brains revealed an unequivocal distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1), which were indistinguishable when normal and beta2m (-/-) mice were compared. In the substantia nigra and basal ganglia, ferric iron and the iron-binding proteins were present in identical cell types, which mainly comprised oligodendrocytes and microglia. Neurons were lightly labelled with transferrin and DMT1. The virtual lack of an increase in cerebral iron in beta2m (-/-) mice clearly shows that the blood-brain barrier (BBB) is capable of restricting the transport of excess plasma iron into the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872742

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  11 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures.

Authors:  Julie A Gaasch; Werner J Geldenhuys; Paul R Lockman; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

Review 3.  Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review.

Authors:  Noemi Russo; Mark Edwards; Thomasin Andrews; Michael O'Brien; Kailash P Bhatia
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 4.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

5.  Iron induces two distinct Ca2+ signalling cascades in astrocytes.

Authors:  Wenzheng Guan; Maosheng Xia; Ming Ji; Beina Chen; Shuai Li; Manman Zhang; Shanshan Liang; Binjie Chen; Wenliang Gong; Chengyi Dong; Gehua Wen; Xiaoni Zhan; Dianjun Zhang; Xinyu Li; Yuefei Zhou; Dawei Guan; Alexei Verkhratsky; Baoman Li
Journal:  Commun Biol       Date:  2021-05-05

6.  Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus.

Authors:  Sandro D Mesquita; Ana C Ferreira; João C Sousa; Nadine C Santos; Margarida Correia-Neves; Nuno Sousa; Joana A Palha; Fernanda Marques
Journal:  Front Cell Neurosci       Date:  2012-05-22       Impact factor: 5.505

7.  Ferritin levels and their association with regional brain volumes in Tourette's syndrome.

Authors:  Daniel A Gorman; Hongtu Zhu; George M Anderson; Mark Davies; Bradley S Peterson
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

Review 8.  Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology.

Authors:  Tina Skjørringe; Annette Burkhart; Kasper Bendix Johnsen; Torben Moos
Journal:  Front Mol Neurosci       Date:  2015-06-08       Impact factor: 5.639

9.  The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.

Authors:  Animesh Alexander Raha; Radhika Anand Vaishnav; Robert Paul Friedland; Adrian Bomford; Ruma Raha-Chowdhury
Journal:  Acta Neuropathol Commun       Date:  2013-09-03       Impact factor: 7.801

Review 10.  Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration.

Authors:  Hjalte Holm Andersen; Kasper Bendix Johnsen; Torben Moos
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.